| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Seres Therapeutics, Inc. (MCRB) have been net sellers, shedding 490 shares worth roughly $2K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 12.5K | $24.5K | - | |
| Other | 8.7K | $17.0K | - | |
| Other | 8.6K | $16.8K | - | |
| Other | 8.1K | $15.9K | - | |
| Other | 8.0K | $15.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 30, 2023 | Eric D. Shaff69 | CEO and President | Sale+OE10b5-1 | 8,552 | $1.35 | $11,545.20 | -6.9% | -13.8% | -46.8% | |
| Oct 30, 2023 | Teresa L. Young72 | See Remarks | Sale+OE10b5-1 | 2,907 | $1.35 | $3,924.45 | -25.6% | -13.8% | -46.8% | |
| Oct 30, 2023 | David Arkowitz61 | Chief Financial Officer | Sale+OE10b5-1 | 4,066 | $1.35 | $5,489.10 | -2.3% | -13.8% | -46.8% | |
| Oct 30, 2023 | Thomas DesRosier69 | Chief Legal Officer and EVP | Sale+OE10b5-1 | 4,156 | $1.35 | $5,610.60 | -3.5% | -13.8% | -46.8% | |
| Oct 30, 2023 | David S. Ege80 | See Remarks | Sale+OE10b5-1 | 4,066 | $1.35 | $5,489.10 | -5.7% | -13.8% | -46.8% | |
| Oct 30, 2023 | Lisa von Moltke65 | See Remarks | Sale+OE10b5-1 | 4,232 | $1.35 | $5,713.20 | -30.8% | -13.8% | -46.8% | |
| Oct 30, 2023 | Matthew R. Henn69 | See Remarks | Sale+OE10b5-1 | 3,886 | $1.35 | $5,246.10 | -6.5% | -13.8% | -46.8% | |
| Apr 28, 2023 | David S. Ege80 | See Remarks | Sell | 7,038 | $5.19 | $36,527.22 | -10.5% | -9.3% | -83.1% | |
| Oct 31, 2022 | David S. Ege80 | See Remarks | Sell | 5,012 | $7.93 | $39,745.16 | -9.7% | -38.4% | -82.7% | |
| Jul 5, 2022 | Nutritional Health Ltp Fund General Partner LLC | 10% Owner | Buy | 8,738,243 | $3.15 | $27,525,465.45 | -300.0% | +61.6% | +24.3% |